Current health risk assessment practice for dietary cadmium: data from different countries
Many people benefit from beginning treatment at minimal concentrations, then adjusting upward as their body adapts
If daytime urinary frequency interferes with work or sleep, talk to your prescriber rather than restricting fluids on your own
Biosimilar Interchangeability: The Extra Layer of Entry Barrier Beyond biosimilar approval, a biosimilar manufacturer can seek an interchangeability designation from the FDA, which allows pharmacists to substitute the biosimilar for the reference product without prescriber intervention, as they do with generic small-molecule drugs
The Problems with Current GLP-1 Guidelines Traditional medicine waits to prescribe GLP-1 medications until a patients BMI hits 30 (obesity) or 27 with at least one weight-related health condition, such as high blood pressure or high cholesterol
This is a common pattern of somewhat lower weight loss with GLP-1-based therapies in patients with diabetes